Studies of gene variants related to inflammation, oxidative stress, dyslipidemia, and obesity: Implications for a nutrigenetic approach

Journal of Obesity

Volumn 2011, Issue , 2011, Pages

  Curti, Maira Ladeia R ^a   Jacob, Patrícia ^a   Borges, Maria Carolina ^a   Rogero, Marcelo Macedo ^a   Ferreira, Sandra Roberta G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84860881446     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2011/497401     Document Type: Article

References (252)

1. WHO, Obesity: Preventing and Managing the Global Epidemic 2003 Geneva, Switzerland World Health Organization WHO Technical Report Series, 894
2. Ogden C. L., Yanovski S. Z., Carroll M. D., Flegal K. M., The epidemiology of obesity. Gastroenterology 2007 132 6 2087 2102 2-s2.0-34247851021 10.1053/j.gastro.2007.03.052 (Pubitemid 46693751)
3. Galuska D. A., Gillespie C., Kuester S. A., Mokdad A. H., Cogswell M. E., Philip C. M., State-specific prevalence of obesity among adults-United States, 2007. Morbidity and Mortality Weekly Report 2008 57 28 765 768
4. Instituto Brasileiro de Geografia e Estatistica (IBGE), Diretoria de Pesquisas, Coordenaçã de Trabalho e Rendimento. Pesquisa de Orçamentos Familiares 2008-2009 2010 Rio de Janeiro, Brazil Instituto Brasileiro de Geografia e Estatistica
5. Kelly T., Yang W., Chen C. S., Reynolds K., He J., Global burden of obesity in 2005 and projections to 2030. International Journal of Obesity 2008 32 9 1431 1437 2-s2.0-51849146897 10.1038/ijo.2008.102
6. de Lorenzo A., delorenzo@uniroma2.it del Gobbo V., Premrov M. G., Bigioni M., Galvano F., Di Renzo L., Normal-weight obese syndrome: early inflammation? The American Journal of Clinical Nutrition 2007 85 1 40 45 (Pubitemid 46067613)
7. Kopelman P. G., Obesity as a medical problem. Nature 2000 404 6778 635 643 2-s2.0-0034611791 (Pubitemid 30205068)
8. Hotamisligil G. S., ghotamis@hsph.harvard.edu Inflammatory pathways and insulin action. International Journal of Obesity 2003 27 supplement 3 S53 S55 10.1038/sj.ijo.0802502 (Pubitemid 38019190)
9. Boden G., bodengh@tuhs.temple.edu Shulman G. I., gerald.shulman@yale.edu Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β -cell dysfunction. European Journal of Clinical Investigation 2002 32 supplement 3 14 23 10.1046/j.1365-2362.32.s3. 3.x (Pubitemid 41704996)
10. Ortsäter H., henrik.ortsater@sodersjukhuset.se Arachidonic acid fights palmitate: new insights into fatty acid toxicity in β -cells. Clinical Science 2011 120 5 179 181 10.1042/CS20100521
11. Barroso S. G., Abreu V. G., Francischetti E. A., The adipose tissue in the genesis of hypertension and atherosclerotic cardiovascular disease. An emerging concept. Arquivos Brasileiros de Cardiologia 2002 78 6 618 630 2-s2.0-0036597779
12. Popkin B. M., Nutrition in transition: the changing global nutrition challenge. Asia Pacific Journal of Clinical Nutrition 2001 10 S13 S18 2-s2.0-0035237015 (Pubitemid 33739437)
13. WHO, Diet, Nutrition and the Prevention of Chronic Diseases. Report of a Joint WHO/FAO Expert Consultation 2003 Geneva, Switzerland World Health Organization WHO Technical Report Series, 916
14. Sinha R., Fisch G., Teague B., Tamborlane W. V., Banyas B., Allen K., Savoye M., Rieger V., Taksali S., Barbetta G., Sherwin R. S., Caprio S., Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. The New England Journal of Medicine 2002 346 11 802 810 2-s2.0-0037076025 10.1056/NEJMoa012578 (Pubitemid 34984653)
15. Reaven G. M., Role of insulin resistance in human disease. Diabetes 1988 37 12 1595 1607 2-s2.0-0024160877 (Pubitemid 19004941)
16. Boden G., Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver. Current Diabetes Reports 2006 6 3 177 181 2-s2.0-33745239304 10.1007/s11892-006-0031-x
17. Arner P., Insulin resistance in type 2 diabetes: role of fatty acids. Diabetes/Metabolism Research and Reviews 2002 18 2 S5 S9 2-s2.0-0036254607 10.1002/dmrr.254 (Pubitemid 34467308)
18. Hotamisligil G. S., Arner P., Caro J. F., Atkinson R. L., Spiegelman B. M., Increased adipose tissue expression of tumor necrosis factor- α in human obesity and insulin resistance. The Journal of Clinical Investigation 1995 95 5 2409 2415 2-s2.0-0028931724
19. Green A., Dobias S. B., Walters D. J. A., Brasier A. R., Tumor necrosis factor increases the rate of lipolysis in primary cultures of adipocytes without altering levels of hormone-sensitive lipase. Endocrinology 1994 134 6 2581 2588 2-s2.0-0028302002 10.1210/en.134.6.2581 (Pubitemid 24170874)
20. Rydén M., Arvidsson E., Blomqvist L., Perbeck L., Dicker A., Arner P., Targets for TNF- α -induced lipolysis in human adipocytes. Biochemical and Biophysical Research Communications 2004 318 1 168 175 2-s2.0-1942424955 10.1016/j.bbrc.2004.04.010 (Pubitemid 38526261)
21. Yudkin J. S., Juhan-Vague I., Hawe E., Humphries S. E., Di Minno G., Margaglione M., Tremoli E., Kooistra T., Morange P. E., Lundman P., Mohamed-Ali V., Hamsten A., Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism 2004 53 7 852 857 2-s2.0-3042621265 10.1016/j.metabol.2004.02.004 (Pubitemid 38829457)
22. Wexler D. J., Hu F. B., Manson J. E., Rifai N., Meigs J. B., Mediating effects of inflammatory biomarkers on insulin resistance associated with obesity. Obesity Research 2005 13 10 1772 1783 2-s2.0-33644795973
23. Fernández-Real J. M., Ricart W., Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocrine Reviews 2003 24 3 278 301 2-s2.0-0037631831 (Pubitemid 36724371)
24. Ando K., Fujita T., Metabolic syndrome and oxidative stress. Free Radical Biology & Medicine 2009 47 3 213 218 2-s2.0-67349273307 10.1016/j.freeradbiomed.2009.04.030
25. Gwathmey T. M., Westwood B. M., Pirro N. T., Tang L., Rose J. C., Diz D. I., Chappell M. C., mchappel@wfubmc.edu Nuclear angiotensin-(1-7) receptor is functionally coupled to the formation of nitric oxide. American Journal of Physiology 2010 299 5 F983 F990 10.1152/ajprenal.00371.2010
26. Ogihara T., Asano T., Katagiri H., Sakoda H., Anai M., Shojima N., Ono H., Fujishiro M., Kushiyama A., Fukushima Y., Kikuchi M., Noguchi N., Aburatani H., Gotoh Y., Komuro I., Fujita T., Oxidative stress induces insulin resistance by activating the nuclear factor- B pathway and disrupting normal subcellular distribution of phosphatidylinositol 3-kinase. Diabetologia 2004 47 5 794 805 2-s2.0-2942569351 10.1007/s00125-004-1391-x (Pubitemid 38756991)
27. Sofi F., francescosofi@gmail.com Abbate R., Gensini G. F., Casini A., Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. The American Journal of Clinical Nutrition 2010 92 5 1189 1196 10.3945/ajcn.2010.29673
28. Sishi B., Loos B., Ellis B., Smith W., Du Toit E. F., Engelbrecht A.-M., ame@sun.ac.za Diet-induced obesity alters signalling pathways and induces atrophy and apoptosis in skeletal muscle in a prediabetic rat model. Experimental Physiology 2011 96 2 179 193 10.1113/expphysiol.2010.054189
29. Figueras M., Olivan M., Busquets S., López-Soriano F. J., Argilés J. M., jargiles@ub.edu Effects of eicosapentaenoic acid (EPA) treatment on insulin sensitivity in an animal model of diabetes: improvement of the inflammatory status. Obesity 2011 19 2 362 369 10.1038/oby.2010.194
30. Riccardi G., Giacco R., Rivellese A. A., Dietary fat, insulin sensitivity and the metabolic syndrome. Clinical Nutrition 2004 23 4 447 456 2-s2.0-4243098381 10.1016/j.clnu.2004.02.006 (Pubitemid 39107022)
31. Bunn R. C., bunnrobertc@uams.edu Cockrell G. E., cockrellgaele@uams.edu Ou Y., ouyang@uams.edu Thrailkill K. M., thrailkillkathrynm@uams.edu Lumpkin C. K. Jr., lumpkincharlesk@uams.edu Fowlkes J. L., fowlkesjohnl@uams.edu Palmitate and insulin synergistically induce IL-6 expression in human monocytes. Cardiovascular Diabetology 2010 9, article 73 10.1186/1475-2840-9-73
32. Chavez J. A., Summers S. A., Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Archives of Biochemistry and Biophysics 2003 419 2 101 109 2-s2.0-0142164965 10.1016/j.abb.2003.08.020 (Pubitemid 37329976)
33. Kennedy A., Martinez K., Chuang C. C., Lapoint K., Mcintosh M., Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications. The Journal of Nutrition 2009 139 1 1 4 2-s2.0-58649096801 10.3945/jn.108.098269
34. Esposito K., Marfella R., Ciotola M., Di Palo C., Giugliano F., Giugliano G., D'Armiento M., D'Andrea F., Giugliano D., Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. Journal of the American Medical Association 2004 292 12 1440 1446 2-s2.0-4544288392 10.1001/jama.292.12.1440 (Pubitemid 39258336)
35. Raqib R., Cravioto A., Nutrition, immunology, and genetics: future perspectives. Nutrition Reviews 2009 67 S227 S236 2-s2.0-77949683751
36. Gibney M. J., Gibney E. R., Diet, genes and disease: implications for nutrition policy. Proceedings of the Nutrition Society 2004 63 3 491 500 2-s2.0-4344712447 10.1079/PNS2004369 (Pubitemid 39145511)
37. Memisoglu A., amemisog@hsph.harvard.edu Hu F. B., Hankinson S. E., Manson J. E., De Vivo I., Willett W. C., Hunter D. J., Interaction between a peroxisome proliferator-activated receptor γ gene polymorphism and dietary fat intake in relation to body mass. Human Molecular Genetics 2003 12 22 2923 2929 10.1093/hmg/ddg318 (Pubitemid 37442020)
38. Martínez J. A., Corbalán M. S., Sánchez-Villegas A., Forga L., Marti A., Martínez-González M. A., Obesity risk is associated with carbohydrate intake in women carrying the Gln27Glu β -adrenoceptor polymorphism. The Journal of Nutrition 2003 133 8 2549 2554 2-s2.0-17744403132 (Pubitemid 36935968)
39. Danawati C. W., Nagata M., Moriyama H., Hara K., Yasuda H., Nakayama M., Kotani R., Yamada K., Sakata M., Kurohara M., Wiyono P., Asdie H., Sakaue M., Taniguchi H., Yokono K., A possible association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor γ 2 gene with obesity in native Javanese in Indonesia. Diabetes/Metabolism Research and Reviews 2005 21 5 465 469 2-s2.0-24944541350 10.1002/dmrr.543 (Pubitemid 41320658)
40. Jones A. B., Peroxisome proliferator-activated receptor (PPAR) modulators: diabetes and beyond. Medicinal Research Reviews 2001 21 6 540 552 2-s2.0-0034798741 10.1002/med.1025 (Pubitemid 32959242)
41. Torra I. P., Chinetti G., Duval C., Fruchart J. C., Staels B., Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice. Current Opinion in Lipidology 2001 12 3 245 254 2-s2.0-0034993832 10.1097/00041433-200106000-00002 (Pubitemid 32521948)
42. Aldhoon B., aldhoon@gmail.com Zamrazilová H., Aldhoon Hainerová I., Šrámková P., Spálová J., Kunešová M., Bendlová B., Hainer V., Role of the PPAR α Leu162Val and PPAR γ 2 Pro12Ala gene polymorphisms in weight change after 2.5-year follow-up in Czech obese women. Folia Biologica 2010 56 3 116 123
43. Deeb S. S., deeb@genetics.washington.edu Fajas L., Nemoto M., Pihlajamäki J., Mykkänen L., Kuusisto J., Laakso M., Fujimoto W., Auwerx J., A Pro12Ala substitution in PPAR γ 2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nature Genetics 1998 20 3 284 287 10.1038/3099 (Pubitemid 28507675)
44. Frederiksen L., Brødbæk K., Fenger M., Jørgensen T., Borch-Johnsen K., Madsbad S., Urhammer S. A., Comment: Studies of the Pro12Ala polymorphism of the PPAR- γ gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome. The Journal of Clinical Endocrinology and Metabolism 2002 87 8 3989 3992 2-s2.0-4243353569 10.1210/jc.87.8.3989 (Pubitemid 34879559)
45. Mori H., Ikegami H., Kawaguchi Y., Seino S., Yokoi N., Takeda J., Inoue I., Seino Y., Yasuda K., Hanafusa T., Yamagata K., Awata T., Kadowaki T., Hara K., Yamada N., Gotoda T., Iwasaki N., Iwamoto Y., Sanke T., Nanjo K., Oka Y., Matsutani A., Maeda E., Kasuga M., kasuga@med.kobe-u.ac.jp The Pro12 → Ala substitution in PPAR- γ is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes 2001 50 4 891 894 (Pubitemid 32242650)
46. Altshuler D., Hirschhorn J. N., Klannemark M., Lindgren C. M., Vohl M. C., Nemesh J., Lane C. R., Schaffner S. F., Bolk S., Brewer C., Tuomi T., Gaudet D., Hudson T. J., Daly M., Groop L., Lander E. S., The common PPAR γ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nature Genetics 2000 26 1 76 80 2-s2.0-0033624575 10.1038/79216
47. Lu Y., Ye X., Cao Y., Li Q., Yu X., Cheng J., Gao Y., Ma J., Du W., Zhou L., Genetic variants in peroxisome proliferator-activated receptor- γ and retinoid X receptor- α gene and type 2 diabetes risk: a case-control study of a Chinese han population. Diabetes Technology and Therapeutics 2011 13 2 157 164 10.1089/dia.2010.0122
48. Masud S., Ye S., Effect of the peroxisome proliferates activated receptor- γ gene Pro12Ala variant on body mass index: a meta-analysis. Journal of Medical Genetics 2003 40 10 773 780 2-s2.0-0142209179 (Pubitemid 37311078)
49. Beamer B. A., Yen C.-J., Andersen R. E., Muller D., Elahi D., Cheskin L. J., Andres R., Roth J., Shuldiner A. R., ashuldin@umppal.ab.umd.edu Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor- γ 2 gene with obesity in two Caucasian populations. Diabetes 1998 47 11 1806 1808 10.2337/diabetes.47.11.1806 (Pubitemid 28476259)
50. Tai E. S., Corella D., Deurenberg-Yap M., Adiconis X., Chew S. K., Tan C. E., Ordovas J. M., Differential effects of the C1431T and Pro12Ala PPAR γ gene variants on plasma lipids and diabetes risk in an Asian population. Journal of Lipid Research 2004 45 4 674 685 2-s2.0-1642465495 10.1194/jlr.M300363-JLR200 (Pubitemid 38405674)
51. Oh E. Y., Min K. M., Chung J. H., Min Y. K., Lee M. S., Kim K. W., Lee M. K., Significance of ProAla mutation in peroxisome proliferator-activated receptor- γ 2 in Korean diabetic and obese subjects. The Journal of Clinical Endocrinology and Metabolism 2000 85 5 1801 1804 2-s2.0-0034186496 10.1210/jc.85.5.1801 (Pubitemid 32269279)
52. Muller Y. L., Bogardus C., Beamer B. A., Shuldiner A. R., Baier L. J., A functional variant in the peroxisome proliferator-activated receptor γ 2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians. Diabetes 2003 52 7 1864 1871 2-s2.0-0037677523 (Pubitemid 36792480)
53. Rosmond R., Chagnon M., Bouchard C., The Pro12Ala PPAR γ 2 gene missense mutation is associated with obesity and insulin resistance in Swedish middle-aged men. Diabetes/Metabolism Research and Reviews 2003 19 2 159 163 2-s2.0-0037359269 10.1002/dmrr.371 (Pubitemid 36417201)
54. González Sánchez J. L., Serrano Ríos M., Fernández Pérez C., Laakso M., Martínez Larrad M. T., Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ -2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population. European Journal of Endocrinology 2002 147 4 495 501 (Pubitemid 35238145)
55. Mirzaei H., Akrami S. M., Golmohammadi T., Doosti M., Heshmat R., Nakhjavani M., Amiri P., Polymorphism of Pro12Ala in the peroxisome proliferator-activated receptor 2 gene in Iranian diabetic and obese subjects. Metabolic Syndrome and Related Disorders 2009 7 5 453 458 2-s2.0-70350303944 10.1089/met.2008.0099
56. Mattevi V. S., Zembrzuski V. M., Hutz M. H., Effects of a PPARG gene variant on obesity characteristics in Brazil. Brazilian Journal of Medical and Biological Research 2007 40 7 927 932 2-s2.0-34547768729 (Pubitemid 47232877)
57. Morini E., Tassi V., Capponi D., Ludovico O., Dallapiccola B., Trischitta V., vincenzo.trischitta@uniroma1.it Prudente S., s.prudente@css-mendel.it Interaction between PPAR γ 2 variants and gender on the modulation of body weight. Obesity 2008 16 6 1467 1470 10.1038/oby.2008.225 (Pubitemid 351770520)
58. Dedoussis G. V., Vidra N., Butler J., Papoutsakis C., Yannakoulia M., Hirschhorn J. N., Lyon H. N., Peroxisome proliferator-activated receptor- γ (PPAR γ) Pro12Ala polymorphism and risk for pediatric obesity. Clinical Chemistry and Laboratory Medicine 2009 47 9 1047 1050 2-s2.0-70349501470 10.1515/CCLM.2009.242
59. Ghoussaini M., Meyre D., Lobbens S., Charpentier G., Clément K., Charles M. A., Tauber M., Weill J., Froguel P., Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population. BMC Medical Genetics 2005 6, article 11 2-s2.0-26444588777 10.1186/1471-2350-6-11 (Pubitemid 41418159)
60. Stefanski A., Majkowska L., Ciechanowicz A., Frankow M., Safranow K., Parczewski M., Pilarska K., Lack of association between the Pro12Ala polymorphism in PPAR- γ 2 gene and body weight changes, insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes. Archives of Medical Research 2006 37 6 736 743 2-s2.0-33745677651 10.1016/j.arcmed.2006.01.009 (Pubitemid 43975172)
61. Helwig U., Rubin D., Kiosz J., Schreiber S., Fölsch U. R., Nothnagel M., Döring F., Schrezenmeir J., The minor allele of the PPAR γ 2 Pro12Ala polymorphism is associated with lower postprandial TAG and insulin levels in non-obese healthy men. British Journal of Nutrition 2007 97 5 847 854 2-s2.0-34147104587 10.1017/S0007114507665179 (Pubitemid 46554399)
62. Cecil J. E., Watt P., Palmer C. N., Hetherington M., Energy balance and food intake: the role of PPAR γ gene polymorphisms. Physiology & Behavior 2006 88 3 227 233 2-s2.0-33745214257 10.1016/j.physbeh.2006.05.028
63. Milewicz A., Tworowska-Bardziñska U., Dunajska K., Jêdrzejuk D., Lwow F., Relationship of PPARgamma2 polymorphism with obesity ana metabolic syndrome in postmenopausal Polish women. Experimental and Clinical Endocrinology and Diabetes 2009 117 10 628 632 2-s2.0-70450247061 10.1055/s-0028-1112154
64. Franks P. W., Jablonski K. A., Delahanty L., Hanson R. L., Kahn S. E., Altshuler D., Knowler W. C., Florez J. C., The Pro12Ala variant at the peroxisome proliferator-activated receptor γ gene and change in obesity-related traits in the Diabetes Prevention Program. Diabetologia 2007 50 12 2451 2460 2-s2.0-35848936503 10.1007/s00125-007-0826-6 (Pubitemid 350060645)
65. Moon M. K., Cho Y. M., Jung H. S., Park Y. J., Yoon K. H., Sung Y. A., Park B. L., Lee H. K., Park K. S., Shin H. D., Genetic polymorphisms in peroxisome proliferator-activated receptor γ are associated with type 2 diabetes mellitus and obesity in the Korean population. Diabetic Medicine 2005 22 9 1161 1166 2-s2.0-24044534766 10.1111/j.1464-5491.2005.01599.x (Pubitemid 41224174)
66. Rosado E. L., Bressan J., Martins M. F., Cecon P. R., Martínez J. A., Polymorphism in the PPARgamma2 and beta2-adrenergic genes and diet lipid effects on body composition, energy expenditure and eating behavior of obese women. Appetite 2007 49 3 635 643 2-s2.0-35748933502 10.1016/j.appet.2007.04.003 (Pubitemid 350047515)
67. Rosado E. L., elianerosado@nutr Bressan J., Hernández J. A. M., Martins M. F., Cecon P. R., Effect of diet and PPAR γ 2 and β 2-adrenergic receptor genes on energy metabolism and body composition in obese women. Nutricion Hospitalaria 2006 21 3 317 331 (Pubitemid 43886459)
68. Luan J., Browne P. O., Harding A. H., Halsall D. J., O'Rahilly S., Chatterjee V. K. K., Wareham N. J., Evidence for gene-nutrient interaction at the PPAR γ locus. Diabetes 2001 50 3 686 689 2-s2.0-0035123646 (Pubitemid 32195237)
69. Soriguer F., Morcillo S., Cardona F., Rojo-Martínez G., Almaráz M. D. L. C., Ruiz De Adana M. D. L. S., Olveira G., Tinahones F., Esteva I., Pro12Ala polymorphism of the PPARG2 gene is associated with type 2 diabetes mellitus and peripheral insulin sensitivity in a population with a high intake of oleic acid. The Journal of Nutrition 2006 136 9 2325 2330 2-s2.0-33748286941 (Pubitemid 44329990)
70. Scaglioni S., Verduci E., Salvioni M., Biondi M. L., Radaelli G., Agostoni C., Giovannini M., PPAR- γ 2 Pro12Ala variant, insulin resistance and plasma long-chain polyunsaturated fatty acids in childhood obesity. Pediatric Research 2006 60 4 485 489 2-s2.0-33748916239 10.1203/01.pdr. 0000238259.41560.00 (Pubitemid 44427605)
71. Grimble R. F., Howell W. M., O'Reilly G., Turner S. J., Markovic O., Hirrell S., East J. M., Calder P. C., The ability of fish oil to suppress tumor necrosis factor α production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor α production. The American Journal of Clinical Nutrition 2002 76 2 454 459 2-s2.0-0036073974 (Pubitemid 34804072)
72. Belisle S. E., Leka L. S., Delgado-Lista J., Jacques P. F., Ordovas J. M., Meydani S. N., Polymorphisms at cytokine genes may determine the effect of vitamin E on cytokine production in the elderly. The Journal of Nutrition 2009 139 10 1855 1860 2-s2.0-70349311439 10.3945/jn.109.112268
73. de Luis D. A., Aller R., Izaola O., Sagrado M. G., Conde R., Influence of G308A promoter variant of tumor necrosis factor- α gene on insulin resistance and weight loss secondary to two hypocaloric diets: a randomized clinical trial. Archives of Medical Research 2009 40 1 36 41 2-s2.0-57149131464 10.1016/j.arcmed.2008.10.012
74. Joffe Y. T., van der Merwe L., Carstens M., Collins M., Jennings C., Levitt N. S., Lambert E. V., Goedecke J. H., Tumor necrosis factor- α gene -308 G/A polymorphism modulates the relationship between dietary fat intake, serum lipids, and obesity risk in black south African women. The Journal of Nutrition 2010 140 5 901 907 2-s2.0-77951449137 10.3945/jn.109.109355
75. Corpeleijn E., Petersen L., Holst C., Saris W. H., Astrup A., Langin D., MacDonald I., Martinez J. A., Oppert J.-M., Polak J., Pedersen O., Froguel P., Arner P., Sørensen T. I. A., Blaak E. E., E.blaak@hb.unimaas.nl Obesity-related polymorphisms and their associations with the ability to regulate fat oxidation in obese Europeans: the NUGENOB study. Obesity 2010 18 7 1369 1377 10.1038/oby.2009.377
76. Razquin C., amarti@unav.es Martinez J. A., Martinez-Gonzalez M. A., Fernández-Crehuet J., Santos J. M., Marti A., A mediterranean diet rich in virgin olive oil may reverse the effects of the-174g/c il6 gene variant on 3-year body weight change. Molecular Nutrition & Food Research 2010 54 supplement 1 S75 S82 10.1002/mnfr.200900257
77. Fernández-Real J. M., Broch M., Vendrell J., Richart C., Ricart W., Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. The Journal of Clinical Endocrinology and Metabolism 2000 85 3 1334 1339 2-s2.0-0034454916 10.1210/jc.85.3.1334 (Pubitemid 32269397)
78. Goyenechea E., Parra M. D., Martínez J. A., jalfmtz@unav.es Weight regain after slimming induced by an energy-restricted diet depends on interleukin-6 and peroxisome-proliferator-activated-receptor- γ 2 gene polymorphisms. British Journal of Nutrition 2006 96 5 965 972 10.1017/BJN20061901 (Pubitemid 46454576)
79. Reiner A. P., Wurfel M. M., Lange L. A., Carlson C. S., Nord A. S., Carty C. L., Rieder M. J., Desmarais C., Jenny N. S., Iribarren C., Walston J. D., Williams O. D., Nickerson D. A., Jarvik G. P., Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 7 1407 1412 2-s2.0-45049083638 10.1161/ATVBAHA.108.167437
80. Yanagisawa A., Suzuki K., ksuzuki@fujita-hu.ac.jp Kimura A., Ito Y., Hamajima N., Inoue T., Possible protective effect of serum β -carotene levels on the association between interleukin-1B C-31T polymorphism and hypertension in a Japanese population. Clinical Nutrition 2009 28 2 198 202 10.1016/j.clnu.2009.01.020
81. Kornman K., Rogus J., Roh-Schmidt H., Krempin D., Davies A. J., Grann K., Randolph R. K., Interleukin-1 genotype-selective inhibition of inflammatory mediators by a botanical: a nutrigenetics proof of concept. Nutrition 2007 23 11-12 844 852 2-s2.0-34948867271 10.1016/j.nut.2007.08.005 (Pubitemid 47532396)
82. Cominetti C., ccominet@usp.br de Bortoli M. C., Purgatto E., Ong T. P., Moreno F. S., Garrido A. B. Jr., Franciscato Cozzolino S. M., Associations between glutathione peroxidase-1 Pro198Leu polymorphism, selenium status, and DNA damage levels in obese women after consumption of Brazil nuts. Nutrition. In press 10.1016/j.nut.2010.09.003
83. Méplan C., Crosley L. K., Nicol F., Horgan G. W., Mathers J. C., Arthur J. R., Hesketh J. E., Functional effects of a common single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene: interaction with sex. The American Journal of Clinical Nutrition 2008 87 4 1019 1027 2-s2.0-42249097442 (Pubitemid 351549249)
84. Méplan C., Crosley L. K., Nicol F., Beckett G. J., Howie A. F., Hill K. E., Horgan G., Mathers J. C., Arthur J. R., Hesketh J. E., j.e.hesketh@ncl.ac.uk Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study). The FASEB Journal 2007 21 12 3063 3074 10.1096/fj.07-8166com
85. Hotamisligil G. S., Shargill N. S., Spiegelman B. M., Adipose expression of tumor necrosis factor- α: direct role in obesity-linked insulin resistance. Science 1993 259 5091 87 91 2-s2.0-0027459878 (Pubitemid 23036092)
86. Lumeng C. N., Deyoung S. M., Saltiel A. R., Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. American Journal of Physiology 2007 292 1 E166 E174 2-s2.0-33846004396 10.1152/ajpendo.00284.2006 (Pubitemid 46052939)
87. Steinberg G. R., Inflammation in obesity is the common link between defects in fatty acid metabolism and insulin resistance. Cell Cycle 2007 6 8 888 894 2-s2.0-34247489726 (Pubitemid 46658739)
88. Louis E., Franchimont D., Piron A., Gevaert Y., Schaaf-Lafontaine N., Roland S., Mahieu P., Malaise M., De Groote D., Louis R., Belaiche J., Tumour necrosis factor (TNF) gene polymorphism influences TNF- α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clinical and Experimental Immunology 1998 113 3 401 406 2-s2.0-7344251714 10.1046/j.1365-2249.1998.00662.x (Pubitemid 28410565)
89. van der Linden M. W., Huizinga T. W. J., Stoeken D. J., Sturk A., Westendorp R. G. J., Determination of tumour necrosis factor- α and interleukin-10 production in a whole blood stimulation system: assessment of laboratory error and individual variation. Journal of Immunological Methods 1998 218 1-2 63 71 2-s2.0-0032170346 10.1016/S0022-1759(98)00108-2 (Pubitemid 28500133)
90. Bayley J. P., de Rooij H., van den Elsen P. J., Huizinga T. W. J., Verweij C. L., Functional analysis of linker-scan mutants spanning the -376, -308, -244, and -238 polymorphic sites of the TNF- α promoter. Cytokine 2001 14 6 316 323 2-s2.0-0035927489 10.1006/cyto.2001.0902 (Pubitemid 32730472)
91. Bayley J. P., Ottenhoff T. H. M., Verweij C. L., Is there a future for TNF promoter polymorphisms? Genes & Immunity 2004 5 5 315 329 2-s2.0-4344579064 10.1038/sj.gene.6364055 (Pubitemid 39139757)
92. Hajeer A. H., Hutchinson I. V., TNF- α gene polymorphism: clinical and biological implications. Microscopy Research and Technique 2000 50 3 216 228 2-s2.0-0034254552 10.1002/1097-0029(20000801)50:3<216::AID-JEMT5>3.0. CO;2-Q (Pubitemid 30610098)
93. Abraham L. J., Kroeger K. M., Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. Journal of Leukocyte Biology 1999 66 4 562 566 2-s2.0-0032881603 (Pubitemid 29489880)
94. Wilson A. G., di Giovine F. S., Blakemore A. I. F., Duff G. W., Single base polymorphism in the human tumour necrosis factor alpha (TNF α) gene detectable by NcoI restriction of PCR product. Human Molecular Genetics 1992 1 5 353
95. Elahi M. M., Asotra K., Matata B. M., Mastana S. S., Tumor necrosis factor alpha -308 gene locus promoter polymorphism: an analysis of association with health and disease. Biochimica et Biophysica Acta 2009 1792 3 163 172 2-s2.0-61349179432 10.1016/j.bbadis.2009.01.007
96. Smith A. J. P., Humphries S. E., Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine and Growth Factor Reviews 2009 20 1 43 59 2-s2.0-60949088752 10.1016/j.cytogfr.2008.11.006
97. Kroeger K. M., Carville K. S., Abraham L. J., The -308 tumor necrosis factor- α promoter polymorphism effects transcription. Molecular Immunology 1997 34 5 391 399 2-s2.0-0030862033 10.1016/S0161-5890(97)00052-7 (Pubitemid 27368335)
98. Wilson A. G., Symons J. A., Mcdowell T. L., Mcdevitt H. O., Duff G. W., Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proceedings of the National Academy of Sciences of the United States of America 1997 94 7 3195 3199 2-s2.0-0030954180 10.1073/pnas.94.7.3195 (Pubitemid 27157287)
99. Kroeger K. M., Steer J. H., Joyce D. A., Abraham L. J., Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism. Cytokine 2000 12 2 110 119 2-s2.0-0033934788 10.1006/cyto.1999.0529 (Pubitemid 30449863)
100. Brinkman B. M. N., Zuijdgeest D., Kaijzel E. L., Breedveld F. C., Verweij C. L., Relevance of the tumor necrosis factor alpha (TNF α) -308 promoter polymorphism in TNF α gene regulation. Journal of Inflammation 1996 46 1 32 41 2-s2.0-0029966034 (Pubitemid 26090860)
101. Araújo F., Pereira A. C., Mota G. F., Latorre M. do R., Krieger J. E., Mansur A. J., The influence of tumor necrosis factor -308 and C-reactive protein G1059C gene variants on serum concentration of C-reactive protein: evidence for an age-dependent association. Clinica Chimica Acta 2004 349 1-2 129 134 2-s2.0-4944249478 10.1016/j.cccn.2004.06.003 (Pubitemid 39328096)
102. Lakka H. M., Lakka T. A., Rankinen T., Rice T., Rao D. C., Leon A. S., Skinner J. S., Bouchard C., The TNF- α G-308A polymorphism is associated with C-reactive protein levels: the HERITAGE Family Study. Vascular Pharmacology 2006 44 5 377 383 2-s2.0-33646129198 10.1016/j.vph.2006.02.002
103. Gander M. L., Fischer J. E., Maly F. E., von Känel R., Effect of the G-308A polymorphism of the tumor necrosis factor (TNF)- α gene promoter site on plasma levels of TNF- α and C-reactive protein in smokers: a cross-sectional study. BMC Cardiovascular Disorders 2004 4, article 17 2-s2.0-13144296644 10.1186/1471-2261-4-17 (Pubitemid 40180350)
104. Sookoian S. C., González C., Pirola C. J., Meta-analysis on the G-308A tumor necrosis factor α gene variant and phenotypes associated with the metabolic syndrome. Obesity Research 2005 13 12 2122 2131 2-s2.0-33645059736
105. Pereira T. V., Rudnicki M., Franco R. F., Pereira A. C., Krieger J. E., Effect of the G-308A polymorphism of the tumor necrosis factor α gene on the risk of ischemic heart disease and ischemic stroke: a meta-analysis. American Heart Journal 2007 153 5 821 830 2-s2.0-34247130850 10.1016/j.ahj.2007.02.031 (Pubitemid 46602156)
106. Phillips C. M., Goumidi L., Bertrais S., Ferguson J. F., Field M. R., Kelly E. D., Mehegan J., Peloso G. M., Adrienne Cupples L., Shen J., Ordovas J. M., McManus R., Hercberg S., Portugal H., Lairon D., Planells R., Roche H. M., Additive effect of polymorphisms in the IL-6, LTA, and TNF- α genes and plasma fatty acid level modulate risk for the metabolic syndrome and its components. The Journal of Clinical Endocrinology and Metabolism 2010 95 3 1386 1394 2-s2.0-77749318422 10.1210/jc.2009-1081
107. Gomez P., Perez-Martinez P., Marin C., Camargo A., Yubero-Serrano E. M., Garcia-Rios A., Rodriguez F., Delgado-Lista J., Perez-Jimenez F., Lopez-Miranda J., APOA1 and APOA4 gene polymorphisms influence the effects of dietary fat on LDL particle size and oxidation in healthy young adults. The Journal of Nutrition 2010 140 4 773 778 2-s2.0-77949713142 10.3945/jn.109.115964
108. Ordovas J. M., Corella D., Cupples L. A., Demissie S., Kelleher A., Coltell O., Wilson P. W. F., Schaefer E. J., Tucker K., Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: the Framingham study. The American Journal of Clinical Nutrition 2002 75 1 38 46 2-s2.0-0036136232 (Pubitemid 34008019)
109. Mata P., Lopez-Miranda J., Pocovi M., Alonso R., Lahoz C., Marin C., Garces C., Cenarro A., Perez-Jimenez F., De Oya M., Ordovas J. M., Human apolipoprotein A-I gene promoter mutation influences plasma low density lipoprotein cholesterol response to dietary fat saturation. Atherosclerosis 1998 137 2 367 376 2-s2.0-17144445460 10.1016/S0021-9150(97)00265-7 (Pubitemid 28215883)
110. Duesing K., Charpentier G., Marre M., Tichet J., Hercberg S., Balkau B., Froguel P., Gibson F., Evaluating the association of common APOA2 variants with type 2 diabetes. BMC Medical Genetics 2009 10, article 13 2-s2.0-61549104407 10.1186/1471-2350-10-13
111. Corella D., Peloso G., Arnett D. K., Demissie S., Cupples L. A., Tucker K., Lai C. Q., Parnell L. D., Coltell O., Lee Y. C., Ordovas J. M., APOA2, dietary fat, and body mass index: replication of a gene-diet interaction in 3 independent populations. Archives of Internal Medicine 2009 169 20 1897 1906 2-s2.0-70449650464 10.1001/archinternmed.2009.343
112. Corella D., Tai E. S., Sorlí J. V., Chew S. K., Coltell O., Sotos-Prieto M., García-Rios A., Estruch R., Ordovas J. M., Association between the APOA2 promoter polymorphism and body weight in Mediterranean and Asian populations: replication of a gene-saturated fat interaction. International Journal of Obesity 2011 35 5 666 675 10.1038/ijo.2010.187
113. Delgado-Lista J., Perez-Jimenez F., Tanaka T., Perez-Martinez P., Jimenez-Gomez Y., Marin C., Ruano J., Parnell L., Ordovas J. M., Lopez-Miranda J., An apolipoprotein A-II polymorphism (-265T/C, rs5082) regulates postprandial response to a saturated fat overload in healthy men. The Journal of Nutrition 2007 137 9 2024 2028 2-s2.0-34548384023 (Pubitemid 47367260)
114. Lai C. Q., Corella D., Demissie S., Cupples L. A., Adiconis X., Zhu Y., Parnell L. D., Tucker K. L., Ordovas J. M., Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study. Circulation 2006 113 17 2062 2070 2-s2.0-33646445485 10.1161/CIRCULATIONAHA.105.577296
115. Mattei J., Demissie S., Tucker K. L., Ordovas J. M., Apolipoprotein A5 polymorphisms interact with total dietary fat intake in association with markers of metabolic syndrome in Puerto Rican older adults. The Journal of Nutrition 2009 139 12 2301 2308 2-s2.0-72249110443 10.3945/jn.109.109900
116. Kim J. Y., Kim O. Y., Koh S. J., Jang Y., Yun S. S., Ordovas J. M., Lee J. H., Comparison of low-fat meal and high-fat meal on postprandial lipemic response in non-obese men according to the -1131T>C polymorphism of the apolipoprotein A5 (APOA5) gene (randomized cross-over design). Journal of the American College of Nutrition 2006 25 4 340 347 2-s2.0-33748769502 (Pubitemid 44414701)
117. Sundl I., Guardiola M., Khoschsorur G., Solà R., Vallvé J. C., Godàs G., Masana L., Maritschnegg M., Meinitzer A., Cardinault N., Roob J. M., Rock E., Winklhofer-Roob B. M., Ribalta J., Increased concentrations of circulating vitamin E in carriers of the apolipoprotein A5 gene -1131T>C variant and associations with plasma lipids and lipid peroxidation. Journal of Lipid Research 2007 48 11 2506 2513 2-s2.0-35848964046 10.1194/jlr.M700285- JLR200 (Pubitemid 350058762)
118. Wu K., Bowman R., Welch A. A., Luben R. N., Wareham N., Khaw K. T., Bingham S. A., Apolipoprotein E polymorphisms, dietary fat and fibre, and serum lipids: the EPIC Norfolk study. European Heart Journal 2007 28 23 2930 2936 2-s2.0-36849021585 10.1093/eurheartj/ehm482 (Pubitemid 350233040)
119. Moreno J. A., Pérez-Jimnéz F., Moreno-Luna R., Pérez-Martínez P., Fuentes-Jimnéz F., Marín C., Portugal H., Lairon D., López-Miranda J., The effect of apoE genotype and sex on ApoE plasma concentration is determined by dietary fat in healthy subjects. British Journal of Nutrition 2009 101 12 1745 1752 2-s2.0-69849093730 10.1017/S0007114508111515
120. Loktionov A., Scollen S., McKeown N., Bingham S. A., Gene-nutrient interactions: dietary behaviour associated with high coronary heart disease risk particularly affects serum LDL cholesterol in apolipoprotein E ε 4-carrying free-living individuals. British Journal of Nutrition 2000 84 6 885 890 (Pubitemid 32106813)
121. Strandhagen E., Zetterberg H., Aires N., Palmér M., Rymo L., Blennow K., Thelle D. S., The apolipoprotein E polymorphism and the cholesterol-raising effect of coffee. Lipids in Health and Disease 2004 3, article 26 2-s2.0-12344262274 10.1186/1476-511X-3-26 (Pubitemid 40132275)
122. Knight J. C., Udalova I., Hill A. V. S., Greenwood B. M., Peshu N., Marsh K., Kwiatkowski D., A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nature Genetics 1999 22 2 145 150 2-s2.0-0032993434 10.1038/9649 (Pubitemid 29264807)
123. Steensberg A., Fischer C. P., Keller C., Møller K., Pedersen B. K., IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. American Journal of Physiology 2003 285 2 E433 E437 2-s2.0-0041846867 (Pubitemid 36899719)
124. Starkie R., Ostrowski S. R., Jauffred S., Febbraio M., Pedersen B. K., Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. The FASEB Journal 2003 17 8 884 886 2-s2.0-0038322493
125. Ghazouani L., ghazouani2005@yahoo.fr Abboud N., Khalifa S. B. H., Added F., Khalfallah A. B., Nsiri B., Mediouni M., Mahjoub T., -174G>C interleukin-6 gene polymorphism in Tunisian patients with coronary artery disease. Annals of Saudi Medicine 2011 31 1 40 44 10.4103/0256-4947.75777
126. Qi L., Zhang C., van Dam R. M., Hu F. B., Interleukin-6 genetic variability and adiposity: associations in two prospective cohorts and systematic review in 26,944 individuals. The Journal of Clinical Endocrinology and Metabolism 2007 92 9 3618 3625 2-s2.0-34548768914 10.1210/jc.2007-0877 (Pubitemid 47435347)
127. Rexrode K. M., Pradhan A., Manson J. E., Buring J. E., Ridker P. M., Relationship of total and abdominal adiposity with CRP and IL-6 in women. Annals of Epidemiology 2003 13 10 674 682 2-s2.0-0242383898 10.1016/S1047-2797(03) 00053-X (Pubitemid 37346407)
128. Vozarova B., Weyer C., Hanson K., Tataranni P. A., Bogardus C., Pratley R. E., Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obesity Research 2001 9 7 414 417 2-s2.0-0035403205 (Pubitemid 33603868)
129. Stephens J. W., J.W.Stephens@Swansea.ac.uk Hurel S. J., Lowe G. D. O., Rumley A., Humphries S. E., Association between plasma IL-6, the IL6 -174G>C gene variant and the metabolic syndrome in type 2 diabetes mellitus. Molecular Genetics and Metabolism 2007 90 4 422 428 10.1016/j.ymgme.2006.10.004 (Pubitemid 46484423)
130. Sattar N., Perry C. G., Petrie J. R., Type 2 diabetes as an inflammatory disorder. British Journal of Diabetes and Vascular Disease 2003 3 1 36 41 2-s2.0-0042888889 (Pubitemid 37045606)
131. Freeman D. J., Norrie J., Caslake M. J., Gaw A., Ford I., Lowe G. D. O., O'Reilly D. S. J., Packard C. J., Sattar N., C-reactive protein is an independent predictor of risk for the development of diabetes in the west of Scotland coronary prevention study. Diabetes 2002 51 5 1596 1600 2-s2.0-0036312978 (Pubitemid 34826630)
132. Humphries S. E., Talmud P. J., Hawe E., Bolla M., Day I. N. M., Miller G. J., Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study. The Lancet 2001 358 9276 115 119 2-s2.0-0035859488 10.1016/S0140-6736(01)05330-2 (Pubitemid 32709850)
133. Fernandez-Real J. M., Vayreda M., Richart C., Gutierrez C., Broch M., Vendrell J., Ricart W., Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. The Journal of Clinical Endocrinology and Metabolism 2001 86 3 1154 1159 2-s2.0-0035049305 10.1210/jc.86.3.1154 (Pubitemid 32322997)
134. Stephens J. W., Hurel S. J., Cooper J. A., Acharya J., Miller G. J., Humphries S. E., A common functional variant in the interleukin-6 gene is associated with increased body mass index in subjects with type 2 diabetes mellitus. Molecular Genetics and Metabolism 2004 82 2 180 186 2-s2.0-2542458388 10.1016/j.ymgme.2004.04.001 (Pubitemid 38692557)
135. Heinrich P. C., Castell J. V., Andus T., Interleukin-6 and the acute phase response. Biochemical Journal 1990 265 3 621 636 2-s2.0-0025190892 (Pubitemid 20053863)
136. Berthier M. T., Paradis A. M., Tchernof A., Bergeron J., Prud'Homme D., Després J. P., Vohl M. C., The interleukin 6 -174G/C polymorphism is associated with indices of obesity in men. Journal of Human Genetics 2003 48 1 14 19 2-s2.0-0037278979 10.1007/s100380300002 (Pubitemid 36205641)
137. Cardellini M., Perego L., D'Adamo M., Marini M. A., Procopio C., Hribal M. L., Andreozzi F., Frontoni S., Giacomelli M., Paganelli M., Pontiroli A. E., Lauro R., Folli F., Sesti G., C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance. Diabetes Care 2005 28 8 2007 2012 2-s2.0-23044505300 10.2337/diacare.28.8.2007 (Pubitemid 41060976)
138. Grallert H., Huth C., Kolz M., Meisinger C., Herder C., Strassburger K., Giani G., Wichmann H. E., Adamski J., Illig T., Rathmann W., IL-6 promoter polymorphisms and quantitative traits related to the metabolic syndrome in KORA S4. Experimental Gerontology 2006 41 8 737 745 2-s2.0-33747139333 10.1016/j.exger.2006.05.002 (Pubitemid 44223893)
139. Hamid Y. H., Rose C. S., Urhammer S. A., Glümer C., Nolsøe R., Kristiansen O. P., Mandrup-Poulsen T., Borch-Johnsen K., Jorgensen T., Hansen T., Pedersen O., Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia 2005 48 2 251 260 2-s2.0-20244369579 10.1007/s00125-004-1623-0 (Pubitemid 40543296)
140. Klipstein-Grobusch K., klipsteingk@sph.wits.ac.za Möhlig M., Spranger J., Hoffmann K., Rodrigues F. U. S., Sharma A. M., Klaus S., Pfeiffer A. F. H., Boeing H., Interleukin-6 g.-174G>C promoter polymorphism is associated with obesity in the EPIC-potsdam study. Obesity 2006 14 1 14 18 10.1038/oby.2006.3 (Pubitemid 46214770)
141. Wernstedt I., Eriksson A.-L., Berndtsson A., Hoffstedt J., Skrtic S., Hedner T., Hultén L. M., Wiklund O., Ohlsson C., Jansson J.-O., JOJ@medic.gu.se A common polymorphism in the interleukin-6 gene promoter is associated with overweight. International Journal of Obesity 2004 28 10 1272 1279 10.1038/sj.ijo.0802763 (Pubitemid 39389584)
142. Goyenechea E., Parra M. D., Hernández J. A. M., Role of IL-6 and its -174G>C polymorphism in weight management and in the metabolic comorbidities associated with obesityImplicacio;n de la IL-6 y su polimorfismo -174G>C en el control del peso corporal y en las complicaciones metabólicas asociadas a la obesidad. Anales del Sistema Sanitario de Navarra 2005 28 3 357 366 2-s2.0-32044460416 (Pubitemid 43191932)
143. Andersson N., Strandberg L., Nilsson S., Adamovic S., Karlsson M. K., Ljunggren O., Mellström D., Lane N. E., Zmuda J. M., Nielsen C., Orwoll E., Lorentzon M., Ohlsson C., Jansson J. O., A variant near the interleukin-6 gene is associated with fat mass in Caucasian men. International Journal of Obesity 2010 34 6 1011 1019 2-s2.0-77953612512 10.1038/ijo.2010.27
144. Huang H. Y., Thuita L., Strickland P., Hoffman S. C., Comstock G. W., Helzlsouer K. J., Frequencies of single nucleotide polymorphisms in genes regulating inflammatory responses in a community-based population. BMC Genetics 2007 8, article 7 2-s2.0-34248144924 10.1186/1471-2156-8-7
145. Poitou C., christine.poitou@ea3502.org Lacorte J.-M., Coupaye M., Bertrais S., Bedel J.-F., Lafon N., Bouillot J.-L., Galan P., Borson-Chazot F., Basdevant A., Coussieu C., Clément K., Relationship between single nucleotide polymorphisms in leptin, IL6 and adiponectin genes and their circulating product in morbidly obese subjects before and after gastric banding surgery. Obesity Surgery 2005 15 1 11 23 10.1381/0960892052993431 (Pubitemid 40203820)
146. McKenzie J. A., Weiss E. P., Ghiu I. A., Kulaputana O., Phares D. A., Ferrell R. E., Hagberg J. M., Influence of the interleukin-6 -174 G/C gene polymorphism on exercise training-induced changes in glucose tolerance indexes. Journal of Applied Physiology 2004 97 4 1338 1342 2-s2.0-4644289990 10.1152/japplphysiol.00199.2004 (Pubitemid 39299349)
147. Kubaszek A., Pihlajamäki J., Punnonen K., Karhapää P., Vauhkonen I., Laakso M., The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity. Diabetes 2003 52 2 558 561 2-s2.0-0037312898 10.2337/diabetes.52.2.558 (Pubitemid 36173216)
148. Vozarova B., Fernández-Real J. M., Knowler W. C., Gallart L., Hanson R. L., Gruber J. D., Ricart W., Vendrell J., Richart C., Tataranni P. A., Wolford J. K., The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Human Genetics 2003 112 4 409 413 2-s2.0-0037849948 (Pubitemid 36869070)
149. Fishman D., Faulds G., Jeffey R., Mohamed-Ali V., Yudkin J. S., Humphries S., Woo P., patricia.woo@ucl.ac.uk The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. The Journal of Clinical Investigation 1998 102 7 1369 1376 (Pubitemid 28467565)
150. Bouhaha R., Baroudi T., Ennafaa H., Vaillant E., Abid H., Sassi R., Vatin V., Froguel P., Gaaied A. B. E., Meyre D., Vaxillaire M., Study of TNF α -308G/A and IL6 -174G/C polymorphisms in type 2 diabetes and obesity risk in the Tunisian population. Clinical Biochemistry 2010 43 6 549 552 2-s2.0-77950859077 10.1016/j.clinbiochem.2010.01.008
151. Brull D. J., d.brull@ucl.ac.uk Montgomery H. E., Sanders J., Dhamrait S., Luong L., Rumley A., Lowe G. D. O., Humphries S. E., Interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 9 1458 1463 (Pubitemid 34219808)
152. Jones K. G., Brull D. J., Brown L. C., Sian M., Greenhalgh R. M., Humphries S. E., Powell J. T., Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 2001 103 18 2260 2265 2-s2.0-0035826716 (Pubitemid 32433715)
153. Eklund C., carita.eklund@uta.fi Nenonen A., Kukkonen-Harjula K., Borg P., Fogelholm M., Laine S., Huhtala H., Lehtimäki T., Hurme M., Association of the IL6-174(G/C) polymorphism with C-reactive protein concentration after weight loss in obese men. European Cytokine Network 2006 17 2 131 135
154. Moleres A., Rendo-Urteaga T., Azcona C., Martínez J. A., Gómez-Martínez S., Ruiz J. R., Moreno L. A., Marcos A., Marti A., IL6 gene promoter polymorphism (-174G/C) influences the association between fat mass and cardiovascular risk factors. Journal of Physiology and Biochemistry 2009 65 4 405 413 2-s2.0-77950807390
155. Berthier M. T., Houde A., Côté M., Paradis A. M., Mauriège P., Bergeron J., Gaudet D., Després J. P., Vohl M. C., Impact of adiponectin gene polymorphisms on plasma lipoprotein and adiponectin concentrations of viscerally obese men. Journal of Lipid Research 2005 46 2 237 244 2-s2.0-13944259663 10.1194/jlr.M400135-JLR200 (Pubitemid 40271087)
156. Ng S. B., Tan Y. H., Guy G. R., Differential induction of the interleukin-6 gene by tumor necrosis factor and interleukin-1. The Journal of Biological Chemistry 1994 269 29 19021 19027 2-s2.0-0028365116 (Pubitemid 24226220)
157. Zhang D., Jiang S. L., Rzewnicki D., Samols D., Kushner I., The effect of interleukin-1 on C-reactive protein expression in Hep3B cells is exerted at the transcriptional level. Biochemical Journal 1995 310 1 143 148 2-s2.0-0029155329
158. Khovidhunkit W., Kim M. S., Memon R. A., Shigenaga J. K., Moser A. H., Feingold K. R., Grunfeld C., Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. Journal of Lipid Research 2004 45 7 1169 1196 2-s2.0-3042606551 10.1194/jlr.R300019-JLR200 (Pubitemid 38802622)
159. Jager J., Grémeaux T., Cormont M., Le Marchand-Brustel Y., Tanti J.-F., tanti@unice.fr Interleukin-1 β -induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 2007 148 1 241 251 10.1210/en.2006-0692 (Pubitemid 46021456)
160. Nicklin M. J. H., Barton J. L., Nguyen M., FitzGerald M. G., Duff G. W., Kornman K., A sequence-based map of the nine genes of the human interleukin-1 cluster. Genomics 2002 79 5 718 725 2-s2.0-0036256462 10.1006/geno.2002.6751 (Pubitemid 34499488)
161. Kornman K. S., kkornman@ilgenetics.com Interleukin 1 genetics, inflammatory mechanisms, and nutrigenetic opportunities to modulate diseases of aging. The American Journal of Clinical Nutrition 2006 83 2 475S 483S (Pubitemid 44713222)
162. Latkovskis G., Licis N., Kalnins U., C-reactive protein levels and common polymorphisms of the interleukin-1 gene cluster and interleukin-6 gene in patients with coronary heart disease. European Journal of Immunogenetics 2004 31 5 207 213 2-s2.0-4744372179 10.1111/j.1365-2370.2004.00476.x (Pubitemid 39315139)
163. Berger P., McConnell J. P., Nunn M., Kornman K. S., Sorrell J., Stephenson K., Duff G. W., C-reactive protein levels are influenced by common IL-1 gene variations. Cytokine 2002 17 4 171 174 2-s2.0-0036059811 10.1006/cyto.2001.0974
164. Iacoviello L., Di Castelnuovo A., Gattone M., Pezzini A., Assanelli D., Lorenzet R., Del Zotto E., Colombo M., Napoleone E., Amore C., D'Orazio A., Padovani A., De Gaetano G., Giannuzzi P., Donati M. B., Polymorphisms of the interleukin-1 β gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 1 222 227 2-s2.0-19944427889 10.1161/01.ATV.0000150039.60906.02 (Pubitemid 40054280)
165. Rafiq S., Stevens K., Hurst A. J., Murray A., Henley W., Weedon M. N., Bandinelli S., Corsi A. M., Guralnik J. M., Ferruci L., Melzer D., Frayling T. M., Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels. Genes & Immunity 2007 8 4 344 351 2-s2.0-34250025351 10.1038/sj.gene.6364393 (Pubitemid 46888042)
166. Shen J., Arnett D. K., Peacock J. M., Parnell L. D., Kraja A., Hixson J. E., Tsai M. Y., Lai C. Q., Kabagambe E. K., Straka R. J., Ordovas J. M., Interleukin1 β genetic polymorphisms interact with polyunsaturated fatty acids to modulate risk of the metabolic syndrome. The Journal of Nutrition 2007 137 8 1846 1851 2-s2.0-34548057795 (Pubitemid 47292728)
167. Kuyl J. M., Mendelsohn D., Observed relationship between ratios HDL-cholesterol/total cholesterol and apolipoprotein A1/apolipoprotein B. Clinical Biochemistry 1992 25 5 313 316 2-s2.0-0026484869 10.1016/0009-9120(92) 80004-Z
168. Perez-Martinez P., Lopez-Miranda J., Perez-Jimenez F., Ordovas J. M., Influence of genetic factors in the modulation of postprandial lipemia. Atherosclerosis Supplements 2008 9 2 49 55 2-s2.0-50849100116 10.1016/j.atherosclerosissup.2008.05.005
169. Sorci-Thomas M., Prack M. M., Dashti N., Johnson F., Rudel L. L., Williams D. L., Differential effects of dietary fat on the tissue-specific expression of the apolipoprotein A-I gene: relationship to plasma concentration of high density lipoproteins. Journal of Lipid Research 1989 30 9 1397 1403 2-s2.0-0024425420 (Pubitemid 19253291)
170. Marcil M., Brooks-Wilson A., Clee S. M., Roomp K., Zhang L. H., Yu L., Collins J. A., van Dam M., Molhuizen H. O. F., Loubster O., Ouellette B. F. F., Sensen C. W., Fichter K., Mott S., Denis M., Boucher B., Pimstone S., Genest J., Kastelein J. J. P., Hayden M. R., Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. The Lancet 1999 354 9187 1341 1346 2-s2.0-0033576209 10.1016/S0140-6736(99)07026-9 (Pubitemid 29481630)
171. Schaefer E. J., Familial lipoprotein disorders and premature coronary artery disease. The Medical Clinics of North America 1994 78 1 21 39 (Pubitemid 24029406)
172. Pisciotta L., Miccoli R., Cantafora A., Calabresi L., Tarugi P., Alessandrini P., Bittolo Bon G., Franceschini G., Cortese C., Calandra S., Bertolini S., Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency. Atherosclerosis 2003 167 2 335 345 2-s2.0-0038801308 10.1016/S0021-9150(03)00020-0 (Pubitemid 36773533)
173. Ikewaki K., Matsunaga A., Han H., Watanabe H., Endo A., Tohyama J. I., Kuno M., Mogi J. I., Sugimoto K. I., Tada N., Sasaki J., Mochizuki S., A novel two nucleotide deletion in the apolipoprotein A-I gene, apoA-I Shinbashi, associated with high density lipoprotein deficiency, corneal opacities, planar xanthomas, and premature coronary artery disease. Atherosclerosis 2004 172 1 39 45 2-s2.0-9144250425 10.1016/j.atherosclerosis.2003.09.024 (Pubitemid 38058599)
174. Yokota H., Hashimoto Y., Okubo S., Yumoto M., Mashige F., Kawamura M., Kotani K., Usuki Y., Shimada S., Kitamura K., Nakahara K., Apolipoprotein A-I deficiency with accumulated risk for CHD but no symptoms of CHD. Atherosclerosis 2002 162 2 399 407 2-s2.0-0036241082 10.1016/S0021-9150(01)00724-9 (Pubitemid 34457946)
175. Rubin E. M., Krauss R. M., Spangler E. A., Verstuyft J. G., Clift S. M., Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A1. Nature 1991 353 6341 265 267 2-s2.0-0025902231 10.1038/353265a0 (Pubitemid 21896769)
176. Herbert P. N., Assmann G., Grotton J. A. M., Fredrickson D. S., Stanbury J. B., Wyngaarden D. S., Fredrickson D. S., Disorders of lipid and lipoprotein metabolism. Metabolic Basis of Inherited Disease 1999 New York, NY, USA McGraw-Hill 589 651
177. Dastani Z., Dangoisse C., Boucher B., Desbiens K., Krimbou L., Dufour R., Hegele R. A., Pajukanta P., Engert J. C., Genest J., Marcil M., A novel nonsense apolipoprotein A-I mutation (apoA-I) causes low HDL cholesterol in French Canadians. Atherosclerosis 2006 185 1 127 136 2-s2.0-30944435268 10.1016/j.atherosclerosis.2005.05.028 (Pubitemid 43117559)
178. Franceschini G., Sirtori C. R., Capurso A., A- I Milano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. The Journal of Clinical Investigation 1980 66 5 892 900 (Pubitemid 11233787)
179. Roma P., Gregg R. E., Meng M. S., Ronan R., Zech L. A., Franceschini G., Sirtori C. R., Brewer H. B., In vivo metabolism of a mutant form of apolipoprotein A-I, apo A- I Milano, associated with familial hypoalphalipoproteinemia. The Journal of Clinical Investigation 1993 91 4 1445 1452 2-s2.0-0027172984 (Pubitemid 23127345)
180. Weisgraber K. H., Rall S. C. Jr., Bersot T. P., Apolipoprotein A- I Milano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I. The Journal of Biological Chemistry 1983 258 4 2508 2513 (Pubitemid 13118451)
181. Calabresi L., Cassinotti M., Gianfranceschi G., Safa O., Murakami T., Sirtori C. R., Franceschini G., Increased postprandial lipemia in apo A- I Milano carriers. Arteriosclerosis and Thrombosis 1993 13 4 521 528 2-s2.0-0027407547 (Pubitemid 23107125)
182. Dan Q., Huang Y., Peng Z., DNA polymorphisms of the apolipoprotein AI-CIII-AIV gene cluster in coronary artery disease. Zhonghua Yi Xue Za Zhi 1995 75 10 584 637 2-s2.0-0029385960
183. Vavatsi N. A., Kouidou S. A., Geleris P. N., Tachumatzidis C., Gikas T., Tsifodimos D. K., Trakatellis A. C., Increased frequency of the rare PstI allele (P2) in a population of CAD patients in Northern Greece. Clinical Genetics 1995 47 1 22 26 2-s2.0-0028872665
184. Jeenah M., Kessling A., Miller N., Humphries S., G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Molecular Biology and Medicine 1990 7 3 233 241 2-s2.0-0025172876 (Pubitemid 20283936)
185. Pagani F., Sidoli A., Giudici G. A., Barenghi L., Vergani C., Baralle F. E., Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia. Journal of Lipid Research 1990 31 8 1371 1377 (Pubitemid 20261901)
186. Marín C., López-Miranda J., Gómez P., Paz E., Pérez-Martínez P., Fuentes F., Jiménez-Perepérez J. A., Ordovás J. M., Pérez-Jiménez F., Effects of the human apolipoprotein A-I promoter G-A mutation on postprandial lipoprotein metabolism. The American Journal of Clinical Nutrition 2002 76 2 319 325 2-s2.0-0036070680 (Pubitemid 34804051)
187. Saha N., Tay J. S. H., Low P. S., Humphries S. E., Guanidine to adenine (G/A) substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI levels in Chinese non-smokers. Genetic Epidemiology 1994 11 3 255 264 2-s2.0-0028238481 10.1002/gepi.1370110304 (Pubitemid 24184734)
188. Groenendijk M., Cantor R. M., de Bruin T. W. A., Dallinga-Thie G. M., The apoAI-CIII-AIV gene cluster. Atherosclerosis 2001 157 1 1 11 2-s2.0-0034974758 10.1016/S0021-9150(01)00539-1 (Pubitemid 32539348)
189. Noriega-López L., Tovar A. R., Gonzalez-Granillo M., Hernández-Pando R., Escalante B., Santillán-Doherty P., Torres N., nimbet@quetzal.innsz.mx Pancreatic insulin secretion in rats fed a soy protein high fat diet depends on the interaction between the amino acid pattern and isoflavones. The Journal of Biological Chemistry 2007 282 28 20657 20666 10.1074/jbc.M701045200 (Pubitemid 47100008)
190. Ascencio C., Torres N., Isoard-Acosta F., Gómez-Pérez F. J., Hernández-Pando R., Tovar A. R., Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats. The Journal of Nutrition 2004 134 3 522 529 2-s2.0-1542286874 (Pubitemid 38298490)
191. Horton J. D., Goldstein J. L., Brown M. S., SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. The Journal of Clinical Investigation 2002 109 9 1125 1131 2-s2.0-0036251153 10.1172/JCI200215593 (Pubitemid 34496588)
192. Torres N., Guevara-Cruz M., Granados J., Vargas-Alarcón G., González-Palacios B., Ramos-Barragan V. E., Quiroz-Olguín G., Flores-Islas I. M., Tovar A. R., Reduction of serum lipids by soy protein and soluble fiber is not associated with the ABCG5/G8, apolipoprotein E, and apolipoprotein A1 polymorphisms in a group of hyperlipidemic Mexican subjects. Nutrition Research 2009 29 10 728 735 2-s2.0-77649221365
193. Berge K. E., Tian H., Graf G. A., Yu L., Grishin N. V., Schultz J., Kwiterovich P., Shan B., Barnes R., Hobbs H. H., Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000 290 5497 1771 1775 2-s2.0-17744390348 10.1126/science.290.5497.1771 (Pubitemid 32004809)
194. Fager G., Wiklund O., Olofsson S. O., Wilhelmsen L., Bondjers G., Multivariate analyses of serum apolipoproteins and risk factors in relation to acute myocardial infarction. Arteriosclerosis 1981 1 4 273 279 2-s2.0-0019800452 (Pubitemid 12229735)
195. Buring J. E., O'Connor G. T., Goldhaber S. Z., Rosner B., Herbert P. N., Blum C. B., Breslow J. L., Hennekens C. H., Decreased HDL and HDL cholesterol, apo A-I and apo A-II, and increased risk of myocardial infarction. Circulation 1992 85 1 22 29 2-s2.0-0026609806
196. Ridker P. M., Rifai N., Cook N. R., Bradwin G., Buring J. E., Non-HDL cholesterol, apolipoproteins A-I and B, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. Journal of the American Medical Association 2005 294 3 326 333 2-s2.0-22244446183 10.1001/jama.294.3.326 (Pubitemid 41043776)
197. Tailleux A., Duriez P., Fruchart J. C., Clavey V., Apolipoprotein A-II, HDL metabolism and atherosclerosis. Atherosclerosis 2002 164 1 1 13 2-s2.0-0035996574 10.1016/S0021-9150(01)00751-1 (Pubitemid 34765632)
198. Escolá-Gil J. C., Marzal-Casacuberta A., Julve-Gil J., Ishida B. Y., Ordóñez-Llanos J., Chan L., González-Sastre F., Blanco-Vaca F., Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: evidence of a potentially relevant species-specific interaction with diet. Journal of Lipid Research 1998 39 2 457 462 2-s2.0-0031936294 (Pubitemid 28100682)
199. Han Z., Heath S. C., Shmulewitz D., Li W., Auerbach S. B., Blundell M. L., Lehner T., Ott J., Stoffel M., Friedman J. M., Breslow J. L., Candidate genes involved in cardiovascular risk factors by a family-based association study on the island of Kosrae, Federated States of Micronesia. American Journal of Medical Genetics 2002 110 3 234 242 2-s2.0-18444402178 10.1002/ajmg.10445 (Pubitemid 34627627)
200. Van't Hooft F. M., Ruotolo G., Boquist S., De Faire U., Eggertsen G., Hamsten A., Human evidence that the apolipoprotein A-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins. Circulation 2001 104 11 1223 1228 2-s2.0-0035845628 (Pubitemid 32848109)
201. Takada D., Emi M., memi@nms.ac.jp Ezura Y., Nobe Y., Kawamura K., Iino Y., Katayama Y., Xin Y., Wu L. L., Larringa-Shum S., Stephenson S. H., Hunt S. C., Hopkins P. N., Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein a-ii promoter: molecular study in a 1135-member familial hypercholesterolemia kindred. Journal of Human Genetics 2002 47 12 656 664 10.1007/s100380200101 (Pubitemid 36083249)
202. Lara-Castro C., Hunter G. R., Lovejoy J. C., Gower B. A., Fernández J. R., Apolipoprotein A-II polymorphism and visceral adiposity in African-American and white women. Obesity Research 2005 13 3 507 512 2-s2.0-22844434875
203. Talmud P. J., Humphries S. E., Genetic polymorphisms, lipoproteins and coronary artery disease risk. Current Opinion in Lipidology 2001 12 4 405 409 2-s2.0-0034914790 10.1097/00041433-200108000-00006 (Pubitemid 32675501)
204. Pennacchio L. A., Olivier M., Hubacek J. A., Cohen J. C., Cox D. R., Fruchart J. C., Krauss R. M., Rubin E. M., An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 2001 294 5540 169 173 2-s2.0-0035812707 10.1126/science.1064852 (Pubitemid 32952971)
205. van der Vliet H. N., Sammels M. G., Leegwater A. C. J., Levels J. H. M., Reitsma P. H., Boers W., Chamuleau R. A. F. M., r.a.chamuleau@amc.uva.nl Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. The Journal of Biological Chemistry 2001 276 48 44512 44520 10.1074/jbc.M106888200
206. Schaap F. G., f.g.schaap@amc.uva.nl Rensen P. C. N., Voshol P. J., Vrins C., van der Vliet H. N., Chamuleau R. A. F. M., Havekes L. M., Groen A. K., van Dijk K. W., ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglycerides (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. The Journal of Biological Chemistry 2004 279 27 27941 27947 10.1074/jbc.M403240200 (Pubitemid 38900062)
207. Fruchart-Najib J., Baugé E., Niculescu L. S., Pham T., Thomas B., Rommens C., Majd Z., Brewer B., Pennacchio L. A., Fruchart J. C., Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5. Biochemical and Biophysical Research Communications 2004 319 2 397 404 2-s2.0-2642532678 10.1016/j.bbrc.2004.05.003 (Pubitemid 38725960)
208. Pennacchio L. A., lapennacchio@lbl.gov Olivier M., Hubacek J. A., Krauss R. M., Rubin E. M., Cohen J. C., Two independent apolipoprotien A5 haplotypes influence human plasma triglyceride levels. Human Molecular Genetics 2002 11 24 3031 3038 (Pubitemid 35414816)
209. Aouizerat B. E., bradley.aouizerat@nursing.ucsf.edu Kulkarni M., Heilbron D., Drown D., Raskin S., Pullinger C. R., Malloy M. J., Kane J. P., Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids. Journal of Lipid Research 2003 44 6 1167 1173 10.1194/jlr.M200480-JLR200 (Pubitemid 37279634)
210. Moreno R., Perez-Jimenez F., Marin C., Moreno J. A., Gomez P., Bellido C., Perez-Martinez P., Jimenez-Gomez Y., Fuentes F. J., Lopez-Miranda J., A single nucleotide polymorphism of the apolipoprotein A-V gene -1131T>C modulates postprandial lipoprotein metabolism. Atherosclerosis 2006 189 1 163 168 2-s2.0-33748956625 10.1016/j.atherosclerosis.2005.11.029 (Pubitemid 44441276)
211. Zhao T., zhaotongfeng@yahoo.com.cn Zhao J., zhaojiangpei1234@yahoo.com.cn Association of the apolipoprotein A5 gene -1131 T>C polymorphism with fasting blood lipids: a meta-analysis in 37859 subjects. BMC Medical Genetics 2010 11 1, article 120 1 12 10.1186/1471-2350-11-120
212. Austin M. A., Talmud P. J., Farin F. M., Nickerson D. A., Edwards K. L., Leonetti D., McNeely M. J., Viernes H. M., Humphries S. E., Fujimoto W. Y., Association of apolipoprotein A5 variants with LDL particle size and triglyceride in Japanese Americans. Biochimica et Biophysica Acta 2004 1688 1 1 9 2-s2.0-12144291123 10.1016/j.bbadis.2003.10.003 (Pubitemid 38366300)
213. Szalai C., Keszei M., Duba J., Prohászka Z., Kozma G. T., Császár A., Balogh S., Almássy Z., Fust G., Czinner A., Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis 2004 173 1 109 114 2-s2.0-10744231400 10.1016/j.atherosclerosis.2003.12.003 (Pubitemid 38224202)
214. Dallongeville J., jean.dallongeville@pasteur-lille.fr Cottel D., Montaye M., Codron V., Amouyel P., Helbecque N., Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men. International Journal of Cardiology 2006 106 2 152 156 10.1016/j.ijcard.2004.10. 065 (Pubitemid 41728931)
215. Corella D., Lai C. Q., Demissie S., Cupples L. A., Manning A. K., Tucker K. L., Ordovas J. M., APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study. Journal of Molecular Medicine 2007 85 2 119 128 2-s2.0-33846650121 10.1007/s00109-006-0147-0 (Pubitemid 46183611)
216. Mahley R. W., Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988 240 4852 622 630 2-s2.0-0024299370
217. Rall S. C. Jr., Weisgraber K. H., Mahley R. W., Human apolipoprotein E. The complete amino acid sequence. The Journal of Biological Chemistry 1982 257 8 4171 4178 2-s2.0-0020490536
218. Mahley R. W., Rall S. C. Jr., Apolipoprotein E: far more than a lipid transport protein. Annual Review of Genomics and Human Genetics 2000 1 2000 507 537 2-s2.0-0034575124
219. Mahley R. W., Ji Z. S., Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. Journal of Lipid Research 1999 40 1 1 16 2-s2.0-0032895028 (Pubitemid 29022581)
220. Taira K., Bujo H., Hirayama S., Yamazaki H., Kanaki T., Takahashi K., Ishii I., Miida T., Schneider W. J., Saito Y., LR11, a mosaic LDL receptor family member, mediates the uptake of apoE-rich lipoproteins in vitro. Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 9 1501 1506 2-s2.0-0035573660 (Pubitemid 34219815)
221. Xhignesse M., Lussier-Cacan S., Sing C. F., Kessling A. M., Davignon J., Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arteriosclerosis and Thrombosis 1991 11 4 1100 1110
222. Huang Y., Liu X. Q., Rail S. C. Jr., Mahley R. W., Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins. The Journal of Biological Chemistry 1998 273 28 17483 17490 10.1074/jbc.273.28.17483 (Pubitemid 28355080)
223. Huang Y., Liu X. Q., Rall S. C. Jr., Taylor J. M., von Eckardstein A., Assmann G., Mahley R. W., Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia. The Journal of Biological Chemistry 1998 273 41 26388 26393 2-s2.0-15644366977 10.1074/jbc.273.41.26388 (Pubitemid 28471643)
224. Rensen P. C. N., van Berkel T. J. C., Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo. The Journal of Biological Chemistry 1996 271 25 14791 14799 2-s2.0-15844414655 10.1074/jbc.271.25.14791 (Pubitemid 26194959)
225. Huang Y., von Eckardstein A., Wu S., Maeda N., Assmann G., A plasma lipoprotein containing only apolipoprotein E and with γ mobility on electrophoresis releases cholesterol from cells. Proceedings of the National Academy of Sciences of the United States of America 1994 91 5 1834 1838 (Pubitemid 24080300)
226. 2+ accumulation in mitogen-activated lymphocytes: role of membrane-bound plasma lipoproteins. Proceedings of the National Academy of Sciences of the United States of America 1980 77 8 4764 4768 2-s2.0-0019052564
227. Miettinen T. A., Gylling H., Vanhanen H., Ollus A., Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes. Arteriosclerosis and Thrombosis 1992 12 9 1044 1052 2-s2.0-0026726414
228. Loktionov A., alex.loktionov@mrc-dunn.cam.ac.uk Vorster H., O'Neill I. K., Nell T., Bingham S. A., Runswick S. A., Cummings J. H., Apolipoprotein E and methylenetetrahydrofolate reductase genetic polymorphisms in relation to other risk factors for cardiovascular disease in UK Caucasians and Black South Africans. Atherosclerosis 1999 145 1 125 135 10.1016/S0021-9150(99)00022-2 (Pubitemid 29292708)
229. Davignon J., Gregg R. E., Sing C. F., Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988 8 1 1 21 2-s2.0-0023860891 (Pubitemid 18049171)
230. Utermann G., Vogelberg K. H., Steinmetz A., Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III. Clinical Genetics 1979 15 1 37 62 2-s2.0-0018341195 (Pubitemid 9114134)
231. Moreno J. A., López-Miranda J., Marín C., Gómez P., Pérez-Martínez P., Fuentes F., Fernández De La Puebla R. A., Paniagua J. A., Ordovas J. M., Pérez-Jiménez F., The influence of the apolipoprotein E gene promoter (-219G/T) polymorphism on postprandial lipoprotein metabolism in young normolipemic males. Journal of Lipid Research 2003 44 11 2059 2064 2-s2.0-0344236147 10.1194/jlr.M300124-JLR200 (Pubitemid 37509621)
232. Alvim R. O., alvimfaefid@ig.com.br Freitas S. R., silvia.sampaio. freitas@hotmail.com Ferreira N. E., noely.ferreira@incor.usp.br Santos P. C., pacaleb@usb.br Cunha R. S., robertos.sa@hotmail.com Mill J. G., jgmill@npd.ufes.br Krieger J. E., krieger@incor.usp.br Pereira A. C., alexandre.pereira@incor.usp.br APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population. Lipids in Health and Disease 2010 9, article 128 1 7 10.1186/1476-511X-9-128
233. Cardona F., Morcillo S., Gonzalo-Marin M., Tinahones F. J., The apolipoprotein E genotype predicts postprandial hypertriglyceridemia in patients with the metabolic syndrome. The Journal of Clinical Endocrinology and Metabolism 2005 90 5 2972 2975 2-s2.0-18844363144 10.1210/jc.2004-1912 (Pubitemid 40686351)
234. Dreon D. M., Fernstrom H. A., Miller B., Krauss R. M., Apolipoprotein E isoform phenotype and LDL subclass response to a reduced-fat diet. Arteriosclerosis, Thrombosis, and Vascular Biology 1995 15 1 105 111 2-s2.0-0028959341
235. Chu F. F., Esworthy R. S., Chu P. G., Longmate J. A., Huycke M. M., Wilczynski S., Doroshow J. H., Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes. Cancer Research 2004 64 3 962 968 2-s2.0-0842304289 10.1158/0008-5472.CAN-03-2272 (Pubitemid 38176898)
236. Brigelius-Flohé R., Tissue-specific functions of individual glutathione peroxidases. Free Radical Biology & Medicine 1999 27 9-10 951 965 2-s2.0-0033230807 10.1016/S0891-5849(99)00173-2 (Pubitemid 29507469)
237. Ran Q., Liang H., Gu M., Qi W., Walter C. A., Roberts L. J., Herman B., Richardson A., van Remmen H., Transgenic mice overexpressing glutathione peroxidase 4 are protected against oxidative stress-induced apoptosis. The Journal of Biological Chemistry 2004 279 53 55137 55146 2-s2.0-11244270281 10.1074/jbc.M410387200 (Pubitemid 40066507)
238. Imai H., Narashima K., Arai M., Sakamoto H., Chiba N., Nakagawa Y., Suppression of leukotriene formation in RBL-2H3 cells that overexpressed phospholipid hydroperoxide glutathione peroxidase. The Journal of Biological Chemistry 1998 273 4 1990 1997 2-s2.0-0031939746 10.1074/jbc.273.4.1990 (Pubitemid 28069244)
239. Villette S., Kyle J. A. M., Brown K. M., Pickard K., Milne J. S., Nicol F., Arthur J. R., Hesketh J. E., A novel single nucleotide polymorphism in the 3 ′ untranslated region of human glutathione peroxidase 4 influences lipoxygenase metabolism. Blood Cells, Molecules, & Diseases 2002 29 2 174 178 2-s2.0-0036399163 10.1006/bcmd.2002.0556 (Pubitemid 35216411)
240. Stadtman T. C., Selenocysteine. Annual Review of Biochemistry 1996 65 83 100 2-s2.0-0030008330 (Pubitemid 26250605)
241. Hatfield D. L., Gladyshev V. N., How selenium has altered our understanding of the genetic code. Molecular and Cellular Biology 2002 22 11 3565 3576 2-s2.0-0036094506 10.1128/MCB.22.11.3565-3576.2002 (Pubitemid 34525202)
242. Kryukov G. V., Castellano S., Novoselov S. V., Lobanov A. V., Zehtab O., Guigó R., Gladyshev V. N., Characterization of mammalian selenoproteomes. Science 2003 300 5624 1439 1443 2-s2.0-0038442808 10.1126/science.1083516 (Pubitemid 36638165)
243. Berry M. J., Banu L., Chen Y., Mandel S. J., Kiefer J. D., Harney J. W., Larsen P. R., Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 3' untranslated region. Nature 1991 353 6341 273 276 2-s2.0-0025743489 10.1038/353273a0 (Pubitemid 21896772)
244. Hesketh J., Nutrigenomics and selenium: gene expression patterns, physiological targets, and genetics. Annual Review of Nutrition 2008 28 157 177 2-s2.0-50949099632 10.1146/annurev.nutr.28.061807.155446
245. Burk R. F., Hill K. E., Selenoprotein P. A selenium-rich extracellular glycoprotein. The Journal of Nutrition 1994 124 10 1891 1897 2-s2.0-0028138963 (Pubitemid 24334623)
246. Hill K. E., Zhou J., McMahan W. J., Motley A. K., Atkins J. F., Gesteland R. F., Burk R. F., Deletion of selenoprotein P alters distribution of selenium in the mouse. The Journal of Biological Chemistry 2003 278 16 13640 13646 2-s2.0-0037515627 10.1074/jbc.M300755200 (Pubitemid 36799899)
247. Schomburg L., Schweizer U., Holtmann B., Flohé L., Sendtner M., Köhrle J., josef.koehrle@charite.de Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochemical Journal 2003 370 2 397 402 10.1042/BJ20021853 (Pubitemid 36315127)
248. Burk R. F., Hill K. E., Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annual Review of Nutrition 2005 25 215 235 2-s2.0-23944498579 10.1146/annurev.nutr.24. 012003.132120 (Pubitemid 41209001)
249. Kabuyama Y., Oshima K., Kitamura T., Homma M., Yamaki J., Munakata M., Homma Y., yoshihom@fmu.ac.jp Involvement of selenoprotein P in the regulation of redox balance and myofibroblast viability in idiopathic pulmonary fibrosis. Genes to Cells 2007 12 11 1235 1244 10.1111/j.1365-2443.2007.01127.x (Pubitemid 350042421)
250. Steinbrenner H., Alili L., Bilgic E., Sies H., Brenneisen P., Involvement of selenoprotein P in protection of human astrocytes from oxidative damage. Free Radical Biology & Medicine 2006 40 9 1513 1523 2-s2.0-33646067098 10.1016/j.freeradbiomed.2005.12.022
251. Steinbrenner H., Bilgic E., Alili L., Sies H., Brenneisen P., Selenoprotein P protects endothelial cells from oxidative damage by stimulation of glutathione peroxidase expression and activity. Free Radical Research 2006 40 9 936 943 10.1080/10715760600806248 (Pubitemid 44480556)
252. Zhang Y., Chen X., xlchen@umn.edu Reducing selenoprotein P expression suppresses adipocyte differentiation as a result of increased preadipocyte inflammation. American Journal of Physiology 2011 300 1 E77 E85 10.1152/ajpendo.00380.2010